Hitinder S. Gurm, MBBS, MD, FSCAI

Original Contribution

Root Cause Analysis of Deaths in ST-Segment Elevation Myocardial Infarctions Treated with Primary PCI: What Can We Do Better?

03/15/2017

Fredy El Sakr , MD;

Mohamad Kenaan , MD;

Daniel Menees , MD;

Milan Seth , BS, MS;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Recent data demonstrate that mortality of patients with ST-elevation myocardial infarction (STEMI) has not changed despite dramatic reduction in door-to-balloon times. Identifying potential areas in care that can be further optimized to...

Recent data demonstrate that...

03/15/2017

Journal of Invasive Cardiology

Original Contribution

Contemporary Trends and Outcomes Associated With the Preprocedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

04/15/2017

Milan Seth , BS, MS;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Devraj Sukul , MD;

Akshay Khandelwal , MD;

Simon R. Dixon , MBChB, FACC, FRACP, MD;

Thomas A. LaLonde , MD;

We sought to describe trends in the use of preprocedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI).

We sought to describe trends in...

04/15/2017

Journal of Invasive Cardiology

The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing PCI (Full Title Below)

10/06/2010

Michael C. Reed , MD;

Dean E. Smith , PhD, MS;

David Share , MD, MPH;

Syed A. Mahmood , MD;

Chris D'Haem , DO;

Richard McNamara , MD;

Adam B. Greenbaum , MD;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Mauro Moscucci , MD;

Thomas A. LaLonde , MD;

The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast Media in Patients Undergoing Percutaneous Coronary Intervention Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

The Relative Renal Safety of...

10/06/2010

Journal of Invasive Cardiology

Original Contribution

Impact of Contrast Dose Reduction on Incidence of Acute Kidney Injury (AKI) Among Patients Undergoing PCI: A Modeling Study

01/15/2016

Roxana Mehran , MD;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Cindy L. Grines , MD, FACC, FSCAI;

Thomas A. LaLonde , MD;

Milan Seth , BS, MS;

Carlo Briguori , MD, PhD;

Louis Cannon , MD, FACC, FACP;

This study estimates projected reduction in the burden of AKI in association with contrast media dose reduction in PCI patients.

This study estimates projected...

01/15/2016

Journal of Invasive Cardiology

The Safety of a Bivalirudin-Based Approach in Patients undergoing Rotational Atherectomy

08/01/2008

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Vivek Rajagopal , MD;

Stephen G. Ellis , MD;

Michael Lincoff , MD;

While contemporary percutaneous coronary intervention (PCI) is predominantly a stent-based strategy, other modalities are occasionally used in lieu of or in addition to stents. Rotational atherectomy uses a high-speed rotating bit to...

While contemporary percutaneous...

08/01/2008

Journal of Invasive Cardiology

Commentary

Defining the Optimal Treatment for Elderly Patients: Lessons from Real-World Data

07/13/2009

Pascal Meier , MD;

Hitinder S. Gurm , MBBS, MD, FSCAI;

The elderly and the very elderly are the most rapidly growing segment of the population in the Western world.1–3 The prevalence of coronary artery disease rises with age, and coronary revascularization is commonly performed in elderly...

The elderly and the very elderly...

07/13/2009

Journal of Invasive Cardiology

Commentary

Drug-Eluting Versus Bare-Metal Stents ‚Äî A One-Horse Race?

01/07/2010

Pascal Meier , MD;

Hitinder S. Gurm , MBBS, MD, FSCAI;

The fact that we are still debating the utility of the bare metal stent (BMS) in 2009 would have seemed unthinkable when the first drug-eluting stent (DES) was approved by the Food and Drug Administration for clinical use in the U.S. in 2003....

The fact that we are still...

01/07/2010

Journal of Invasive Cardiology

Commentary

Anticoagulation during Percutaneous Coronary Intervention in Diabetics ‚Äî Is Simpler Always Better?

02/24/2010

Pascal Meier , MD;

Hitinder S. Gurm , MBBS, MD, FSCAI;

Bivalirudin is theoretically a promising alternative to unfractionated heparin (UFH). It is a direct thrombin inhibitor and has the ability to block circulating and clot-bound thrombin and prevent thrombin-mediated platelet activation.1...

Bivalirudin is theoretically a...

02/24/2010

Journal of Invasive Cardiology

Commentary

Preventing Contrast-Induced Nephropathy in Patients Undergoing Primary PCI

10/24/2011

Hitinder S. Gurm , MBBS, MD, FSCAI;

Shea E. Hogan , MD;

Contrast-induced nephropathy (CIN) continues to be one of the most common major adverse side effect of cardiac catheterization, and is associated with short- and long-term morbidity and mortality.1,2 This is particularly true in the...

Contrast-induced nephropathy...

10/24/2011

Journal of Invasive Cardiology

Commentary

Balancing the Yin and the Yang of Vascular Closure

02/29/2012

Hitinder S. Gurm , MBBS, MD, FSCAI;

Michael P. Thomas , MD;

Vascular access complications from diagnostic coronary angiography and percutaneous intervention are a major cause of morbidity and mortality. The use of vascular closure devices is common practice and their use to decrease complications is...

Vascular access complications...

02/29/2012

Journal of Invasive Cardiology